Keywords: مهارکننده آنژیوژنز; Squalene extraction; Pumpkin seed oil; Magnetic nanoparticles; Fatty acids; Neural network modeling; Angiogenesis inhibitor;
مقالات ISI مهارکننده آنژیوژنز (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مهارکننده آنژیوژنز; Angiogenesis inhibitor; Cell motility and invasion; Cell proliferation; Combretastatins; Suppression of EMT; Suppression of tumour progression;
Keywords: مهارکننده آنژیوژنز; Angiogenesis inhibitor; Chemotherapy; Combination; Second line; Targeted therapy;
Keywords: مهارکننده آنژیوژنز; Alzheimer's disease; angiogenesis inhibitor; cancer; cinnamon; chronic diseases; diabetes
Keywords: مهارکننده آنژیوژنز; Marmesin; Angiogenesis inhibitor; Vascular endothelial growth factor; VEGFR-2; β1 integrin;
Keywords: مهارکننده آنژیوژنز; Heparin conjugate; Angiogenesis inhibitor; Oral delivery; Chemoprevention; Lung cancer;
Keywords: مهارکننده آنژیوژنز; Titanium dioxide; nanoparticles; toxicity; angiogenesis inhibitor; pathologic angiogenesis;
Keywords: مهارکننده آنژیوژنز; Heparin conjugate; Deoxycholic acid; Angiogenesis inhibitor; Oral delivery;
Polyprenylated polycyclic acylphloroglucinol: Angiogenesis inhibitor from Garcinia multiflora
Keywords: مهارکننده آنژیوژنز; Garcinia multiflora; Guttiferae; Polyprenylated polycyclic acylphloroglucinol; Garcimultiflorone K; Angiogenesis inhibitor;
Intraocular application of gold nanodisks optically tuned for optical coherence tomography: inhibitory effect on retinal neovascularization without unbearable toxicity
Keywords: مهارکننده آنژیوژنز; Gold nanodisk; Near-infrared; Optical coherence tomography; Intraocular application; Angiogenesis inhibitor; Retinal neovascularization;
Anti-angiogenesis through noninvasive to minimally invasive intraocular delivery of the peptide CC12 identified by in vivo-directed evolution
Keywords: مهارکننده آنژیوژنز; Angiogenesis inhibitor; Cell-penetrating peptides; Intraocular drug delivery; In vivo-direction evolution; Neovascularization; Phage display;
Correlation of c-Met Expression and Outcome in Patients With Renal Cell Carcinoma Treated With Sunitinib
Keywords: مهارکننده آنژیوژنز; Angiogenesis inhibitor; c-Met inhibitor; mRCC; Prognostic marker;
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of Aflibercept in Patients With Metastatic Renal Cell Carcinoma (ECOG-ACRIN [E4805])
Keywords: مهارکننده آنژیوژنز; Angiogenesis inhibitor; Antiangiogenesis; Drug resistance; VEGF blocker;
Pemetrexed With Platinum Combination as a Backbone for Targeted Therapy in Non-Small-Cell Lung Cancer
Keywords: مهارکننده آنژیوژنز; Angiogenesis inhibitor; EGFR inhibitor; Nonsquamous; Platinum-doublet chemotherapy;
Phase II trial of recombinant human endostatin in combination with concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer
Keywords: مهارکننده آنژیوژنز; Endostatin; Angiogenesis inhibitor; Radiotherapy; Chemotherapy; Lung cancer;
Traitements comparés de la néovascularisation cornéenne : injections sous-conjonctivales de bévacizumab et/ou photothérapie dynamique
Keywords: مهارکننده آنژیوژنز; Inhibiteur de l'angiogenèse; Néovascularisation cornéenne; Photothérapie dynamique; Angiogenesis inhibitor; Corneal neovascularization; Photodynamic therapy;
A phase II evaluation of nintedanib (BIBF-1120) in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group Study
Keywords: مهارکننده آنژیوژنز; Endometrial cancer; Angiogenesis inhibitor; Clinical trial;
Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29
Keywords: مهارکننده آنژیوژنز; Non-small cell; Phase III; Angiogenesis inhibitor; Systemic therapy;
Synthesis of 3â²-methoxy-E-diethylstilbestrol and its analogs as tumor angiogenesis inhibitors
Keywords: مهارکننده آنژیوژنز; 2-Methoxyestradiol; 3â²-Methoxy-E-diethylstilbestrol; Metabolite; Non-steroidal analog; Angiogenesis inhibitor;
Tumor vasculature targeting following co-delivery of heparin-taurocholate conjugate and suberoylanilide hydroxamic acid using cationic nanolipoplex
Keywords: مهارکننده آنژیوژنز; Heparin-taurocholate conjugate; Angiogenesis inhibitor; Histone deacetylase inhibitor; Cationic nanolipoplex; Tumor vasculature targeting;
Cyclic RGDyk-conjugated LMWH-taurocholate derivative as a targeting angiogenesis inhibitor
Keywords: مهارکننده آنژیوژنز; Heparin-taurocholate; LMWH; cRGD; αvβ3 integrin; Angiogenesis inhibitor
Challenges in the current antiangiogenic treatment paradigm for patients with non-small cell lung cancer
Keywords: مهارکننده آنژیوژنز; Carcinoma; Non-small cell lung; Angiogenesis inhibitor; Protein-tyrosine kinase; Vascular endothelial growth factor; Receptor; Vascular endothelial growth factor; Biological marker
Integration of Surgery and Systemic Therapy for Renal Cell Carcinoma
Keywords: مهارکننده آنژیوژنز; Renal cell carcinoma; Adjuvant therapy; Neoadjuvant therapy; Cytoreductive nephrectomy; Immunotherapy; Targeted therapy; Angiogenesis inhibitor; Tyrosine kinase inhibitor;
Beta-35 is a transferrin-derived inhibitor of angiogenesis and tumor growth
Keywords: مهارکننده آنژیوژنز; BCE; bovine capillary endothelial cells; CAM; chick chorioallantoic membrane; HPLC; high-performance liquid chromatography; Angiogenesis; Angiogenesis inhibitor; Anti-angiogenic therapy;
Phase II Study of Cediranib in Patients with Malignant Pleural Mesothelioma: SWOG S0509
Keywords: مهارکننده آنژیوژنز; Phase 2; Angiogenesis inhibitor; Pleural mesothelioma
Isolation, identification, and biological evaluation of HIF-1-modulating compounds from Brazilian green propolis
Keywords: مهارکننده آنژیوژنز; HIF-1 modulator; Angiogenesis inhibitor; Brazilian green propolis; Drupanin; Tumor microenvironment;
Synthetic studies toward (+)-cortistatin A
Keywords: مهارکننده آنژیوژنز; Total synthesis; Angiogenesis inhibitor; Nitrone-aryne cycloaddition; 6Ï-Electrocyclization;
Efficacy of Thalidomide for Refractory Gastrointestinal Bleeding From Vascular Malformation
Keywords: مهارکننده آنژیوژنز; Treatment; Angiodysplasia; Blood Vessels; Angiogenesis Inhibitor; Clinical Trial; CE; capsule endoscope; EGD; esophagogastroduodenoscopy; GAVE; gastric antral vascular ectasia; GI; gastrointestinal; GIVM; gastrointestinal vascular malformation; iFOBT; imm
DGDA, a local sequence of the kringle 2 domain, is a functional motif of the tissue-type plasminogen activator's antiangiogenic kringle domain
Keywords: مهارکننده آنژیوژنز; DGDA; DGEA; Kringle domain; Integrin α2β1; Angiogenesis inhibitor; Migration;
In vitro and in vivo antiangiogenic activity of a novel deca-peptide derived from human tissue-type plasminogen activator kringle 2
Keywords: مهارکننده آنژیوژنز; Tissue-type plasminogen activator; Kringle domain; Peptide; Angiogenesis inhibitor
Albendazole inhibits endothelial cell migration, tube formation, vasopermeability, VEGF receptor-2 expression and suppresses retinal neovascularization in ROP model of angiogenesis
Keywords: مهارکننده آنژیوژنز; Angiogenesis inhibitor; Albendazole; Bevacizumab; HUVEC; VEGF; VEGFR-2
A horsefly saliva antigen 5-like protein containing RTS motif is an angiogenesis inhibitor
Keywords: مهارکننده آنژیوژنز; Horsefly; Salivary glands; Disintegrin; Angiogenesis inhibitor; Tabanus yao
Intérêt des thérapeutiques ciblées dans les cancers bronchiques non à petites cellules localement avancés, en association avec la radiothérapie
Keywords: مهارکننده آنژیوژنز; Cancer bronchique non à petites cellules; Inhibiteurs de tyrosine kinas; Inhibiteurs de l'angiogenèse; Thérapie ciblée; Radiothérapie; Non-small cell lung cancer; Tyrosine kinase inhibitor; Angiogenesis inhibitor; Targeted therapy; Radiotherapy;
In vivo evaluation of microspheres containing the angiogenesis inhibitor, TNP-470, and the metastasis suppression with liver metastatic model implanted neuroblastoma
Keywords: مهارکننده آنژیوژنز; Drug delivery system; Angiogenesis inhibitor; Neuroblastoma; TNP-470; Biodegradable microsphere
Antiangiogenic Effect of a Selective 5-HT4 Receptor Agonist1
Keywords: مهارکننده آنژیوژنز; HUVECs; mosapride citrate; angiogenesis inhibitor; cell cycle arrest
Impairment of VEGF-A-stimulated lamellipodial extensions and motility of vascular endothelial cells by chondromodulin-I, a cartilage-derived angiogenesis inhibitor
Keywords: مهارکننده آنژیوژنز; Chondromodulin-I; VEGF-A; Angiogenesis inhibitor; Vascular endothelial cell; Cell migration
A new antiangiogenic C24 oxylipin from the soft coral Sinularia numerosa
Keywords: مهارکننده آنژیوژنز; Angiogenesis inhibitor; Tube formation; Marine natural products; Oxylipin
Angiogenesis inhibitor attenuates parathyroid hormone-induced anabolic effect
Keywords: مهارکننده آنژیوژنز; Parathyroid hormone; Angiogenesis inhibitor; Bone strength; Bone formation
Dependence of cathepsin L-induced coronary endothelial dysfunction upon activation of NAD(P)H oxidase
Keywords: مهارکننده آنژیوژنز; Proteinase; Angiogenesis inhibitor; Coronary circulation; Endothelium; Free radicals;
Combination of Vandetanib, Radiotherapy, and Irinotecan in the LoVo Human Colorectal Cancer Xenograft Model
Keywords: مهارکننده آنژیوژنز; Vandetanib; Radiotherapy; CPT-11; LoVo colorectal cancer; Angiogenesis inhibitor;
The effect of omega-3 FAs on tumour angiogenesis and their therapeutic potential
Keywords: مهارکننده آنژیوژنز; Omega-3 fatty acids; Tumour angiogenesis; Angiogenesis inhibitor
The Tyrosine Kinase Inhibitor Cediranib for Non-small Cell Lung Cancer and Other Thoracic Malignancies
Keywords: مهارکننده آنژیوژنز; AZD2171; TKI; NSCLC; angiogenesis inhibitor
Effective delivery of an angiogenesis inhibitor by neovessel-targeted liposomes
Keywords: مهارکننده آنژیوژنز; APRPG-PEG-Lip-SU1498; APRPG-PEG-modified liposomal SU1498; DDS; drug delivery systems; DPPC; dipalmitoylphosphatidylcholine; DPPG; dipalmitoylphosphatidylglycerol; DSPE-PEG-APRPG; distearoylphosphatidylethanolamine-polyethyleneglycol-APRPG peptide conjuga
Open-label, non-randomised, inter-individual dose escalation of ZK 304709 with the evaluation of safety, tolerability, pharmacokinetics, oral bioavailability and orientating efficacy after daily administration in patients with advanced cancer (7 d treatme
Keywords: مهارکننده آنژیوژنز; ZK 304709; Phase I; Cell cycle arrest; Apoptosis induction; Angiogenesis inhibitor
Type IV collagen-derived angiogenesis inhibitors
Keywords: مهارکننده آنژیوژنز; ECM; Angiogenesis inhibitor; Type IV collagen NC1; Tumor
Discovery of N-phenyl nicotinamides as potent inhibitors of Kdr
Keywords: مهارکننده آنژیوژنز; VEGF; VEGFR-2 inhibitor; Kdr inhibitor; Angiogenesis inhibitor; Kinase inhibitor
A biologically active angiogenesis inhibitor, human serum albumin-TIMP-2 fusion protein, secreted from Saccharomyces cerevisiae
Keywords: مهارکننده آنژیوژنز; HSA-TIMP-2; Angiogenesis inhibitor; Recombinant protein; Secretion; Yeast;
Angiogenesis and antiangiogenic therapy in hematologic malignancies
Keywords: مهارکننده آنژیوژنز; Angiogenesis; Antiangiogenic therapy; Angiogenesis activator; Angiogenesis inhibitor; Hematological malignancies
Separation of anti-angiogenic and cytotoxic activities of borrelidin by modification at the C17 side chain
Keywords: مهارکننده آنژیوژنز; Borrelidin; Polyketide; Angiogenesis inhibitor; Biosynthetic engineering
Development of withaferin A analogs as probes of angiogenesis
Keywords: مهارکننده آنژیوژنز; Biotinylated analog; Natural product; Binding protein; Ubiquitin; Angiogenesis inhibitor